1-乙基-1-苯甲酰肼 | 5501-18-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-乙基-1-苯甲酰肼
• 英文名称: N-Aethyl-N-benzoyl-hydrazin
• 英文别名: 1-Ethyl-1-benzoyl hydrazine；N-Ethylbenzohydrazide
• CAS: 5501-18-8
• 化学式: C₉H₁₂N₂O
• 分子量: 164.207
• InChiKey: HAYFQSOFQNMIAM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-乙基-1-苯甲酰肼 在 P₂S₂ 作用下， 以 氘代苯 为溶剂， 生成 thiobenzoic acid N-ethyl-hydrazide
  参考文献：
  名称：

  Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol

  摘要：

  A series of N'(1),N'(3)-dialkyl-N'(1),N'(3)-di(alkylcarbonothioyl) malonohydrazides have been designed and synthesized as anticancer agents by targeting oxidative stress and Hsp70 induction. Structure-activity relationship (SAR) studies lead to the discovery of STA-4783 (elesclomol), a novel small molecule that has been evaluated in a number of clinical trials as an anticancer agent in combination with Taxol. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.07.032
• 作为产物：
  描述：

  苯甲酰氯 、 2-甲基-2-丙基2-乙基肼羧酸酯 在 三乙胺 、 三氟乙酸 、 sodium hydroxide 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 生成 1-乙基-1-苯甲酰肼
  参考文献：
  名称：

  Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol

  摘要：

  A series of N'(1),N'(3)-dialkyl-N'(1),N'(3)-di(alkylcarbonothioyl) malonohydrazides have been designed and synthesized as anticancer agents by targeting oxidative stress and Hsp70 induction. Structure-activity relationship (SAR) studies lead to the discovery of STA-4783 (elesclomol), a novel small molecule that has been evaluated in a number of clinical trials as an anticancer agent in combination with Taxol. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.07.032

文献信息

• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：MISSION THERAPEUTICS LTD

  公开号：WO2016046530A1

  公开（公告）日：2016-03-31

  The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase L1 (UCHL1). The invention further relates to the use of DUB inhibitors in the treatment of cancer and other indications. Compounds of the invention include compounds having the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 to R8 are as defined herein.

  本发明涉及新型化合物和制备去泛素化酶（DUBs）抑制剂的方法。具体而言，本发明涉及抑制泛素C端水解酶L1（UCHL1）。本发明进一步涉及在癌症和其他适应症治疗中使用DUB抑制剂。本发明的化合物包括具有式（I）或其药用可接受盐的化合物，其中R1至R8如本文所定义。
• 7-Oxabicycloheptane hydrazone prostaglandin analogs useful in treating
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US04418076A1

  公开（公告）日：1983-11-29

  7-Oxabicycloheptane hydrazone prostaglandin analogs are provided having the structural formula ##STR1## and including all stereoisomers thereof. pa The compounds are cardiovascular agents useful, for example, in the treatment of thrombolytic disease.

  提供了具有结构式##STR1##的7-Oxabicycloheptane hydrazone前列腺素类似物，包括所有立体异构体。这些化合物是心血管药物，例如在溶栓疾病的治疗中很有用。
• Visible-Light-Driven [3 + 2]/[4 + 2] Annulation Reactions of Alkenes with <i>N</i>-Aminopyridinium Salts
  作者：Yu-Zhao Wang、Peng-Yu Liang、Hong-Chao Liu、Wu-Jie Lin、Pan-Pan Zhou、Wei Yu

  DOI：10.1021/acs.orglett.2c02323

  日期：2022.8.19

  The annulation reactions of benzoamidyl radicals with alkenes were realized under visible light irradiation with fac-Ir(ppy)3 as catalyst and N-aminopyridinium salts as benzoamidyl radical precursors. The reaction can deliver two distinct types of products: in the case of vinyl arenes, [3 + 2] annulation product dihydrooxazoles were yielded exclusively; when alkyl-substituted alkenes were used, on the

  以fac -Ir(ppy) 3为催化剂，N-氨基吡啶鎓盐为苯甲酰胺自由基前体，在可见光照射下实现了苯甲酰胺自由基与烯烃的环化反应。该反应可以产生两种不同类型的产物：在乙烯基芳烃的情况下，仅产生 [3 + 2] 环化产物二氢恶唑；另一方面，当使用烷基取代的烯烃时，它提供了[4 + 2]环化产物二氢异喹啉酮。通过 DFT 计算阐明了决定反应后果的因素。
• LIGANDEN UND KOMPLEXE ZUR ENANTIOSELEKTIVEN HYDRIERUNG
  申请人：dmc2 Degussa Metals Catalysts Cerdec AG

  公开号：EP1140956A1

  公开（公告）日：2001-10-10
• US4418076A
  申请人：——

  公开号：US4418076A

  公开（公告）日：1983-11-29